drugset / Trial / NCT00556998
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study is designed to collect additional pharmacokinetic and safety data of voriconazole in immunocompromised adolescents receiving intravenous and oral voriconazole. This will help establish voriconazole dosing recommendations for adolescents.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voriconazole | Small molecule | 4 mg/kg | Intravenous |
| Subject | Voriconazole | Small molecule | 300 mg | Intravenous |
Indications
No indication recorded.